Challenges and Strategies for Improving Access to Cancer Drugs in Malaysia: Summary of Opinions Expressed at the 2nd MACR International Scientific Conference 2022

Considerable progress has been made in cancer drug development in recent decades. However, for people in low- and middle-income countries, including Malaysia, many of these drugs are not readily available. During the 2nd Malaysian Association for Cancer Research (MACR) International Scientific Confe...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Shing Cheng, Poh, Wen Tsin, Yong, Audrey Chee Hui, Chua, Eng Wee, Ooi, Der Jiun, Mahmud, Rozi, Thiagarajan, Muthukkumaran, Stanslas, Johnson
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Expert Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457461/
https://www.ncbi.nlm.nih.gov/pubmed/37636030
http://dx.doi.org/10.2147/CMAR.S420890

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457461/
https://www.ncbi.nlm.nih.gov/pubmed/37636030
http://dx.doi.org/10.2147/CMAR.S420890

Ejemplares similares